New protein discovered with vast potential for treatment of cancer and other diseases

July 31, 2013

In cancer research, discovering a new protein that plays a role in cancer is like finding a key and a treasure map: follow the clues and eventually there could be a big reward. At least that's the hope from a new study published in the journal Nature that discovered a novel protein called ceramide-1 phosphate transport protein (CPTP)—a finding that could eventually lead to the development of new drugs to treat a variety of cancers and other conditions involving inflammation and thrombosis, or blood clotting.

The identification of CPTP was the result of an that built on prior research by co-lead author Charles Chalfant, Ph.D., Endowed Chair of Cancer Cell Signaling and member of the Cancer Cell Signaling program at Virginia Commonwealth University Massey Cancer Center as well as professor in the Department of Biochemistry and Molecular Biology at VCU School of Medicine. The team discovered that CPTP regulates levels of biologically active lipids, which are molecules such as that often play a role in . As its name implies, this study determined that CPTP's main function is to transport ceramide-1-phosphate (C1P), a lipid that helps regulate cell growth, survival, migration and inflammation. Specifically, C1P increases the production of pro-inflammatory eicosanoids—powerful signaling molecules that contribute to in diseases such as cancer, asthma, atherosclerosis and thrombosis—and the discovery of CPTP shines a light on the that contribute to these diseases.

"We may have identified the newest target for treating cancer," says Chalfant. "Because of the important role this protein plays in a number of , it could also have large implications for a variety of diseases like cancer that are caused by inflammation."

With assistance from Massey's Lipidomics Developing Shared Resource core, the researchers were able to determine the composition of the bioactive lipids regulated by CPTP. Residing in the cytosol, or the liquid within cells, the team found that CPTP regulates catabolism of C1P, a process that breaks down the molecule in order to release its energy. They also demonstrated that CPTP transports C1P to the cellular membrane where it helps synthesize eicosanoids from fatty acids in the membrane.

Confirming a decade of research from Chalfant's laboratory, the scientists provided further proof that C1P regulates group IVA phospholipase A2, an enzyme that promotes inflammation through the production of a fatty acid known as arachidonic acid. The release of arachidonic acid via C1P activation of this enzyme was shown to trigger the production of eicosanoids. These findings help to explain the reported link between ceramide kinase, the enzyme responsible for C1P production, and poor prognosis in breast cancer patients, which further suggests that alleviation of systemic inflammation may lead to better prognosis and better treatment responses.

"Moving forward, we hope to use our knowledge of the structure of CPTP in order to find small molecules and other means that can block it," says Chalfant. "The immediate uses of such therapeutics might be to restore clotting in trauma patients by maintaining the levels of specific eicosanoids that mediate blood clotting. However, with further research we hope to define exactly how CPTP is produced so that we can regulate its production and potentially develop new treatments for a variety of diseases."

Explore further: Multiple sclerosis drug may one day treat colorectal cancer

More information:

Related Stories

Multiple sclerosis drug may one day treat colorectal cancer

January 9, 2013

After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, a drug ...

New drug combination therapy developed to treat leukemia

April 17, 2013

A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival ...

Recommended for you

Researchers grow retinal nerve cells in the lab

November 30, 2015

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. ...

Shining light on microbial growth and death inside our guts

November 30, 2015

For the first time, scientists can accurately measure population growth rates of the microbes that live inside mammalian gastrointestinal tracts, according to a new method reported in Nature Communications by a team at the ...

Functional human liver cells grown in the lab

November 26, 2015

In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. ...

Gut microbes signal to the brain when they are full

November 24, 2015

Don't have room for dessert? The bacteria in your gut may be telling you something. Twenty minutes after a meal, gut microbes produce proteins that can suppress food intake in animals, reports a study published November 24 ...


Adjust slider to filter visible comments by rank

Display comments: newest first

Jul 31, 2013
This comment has been removed by a moderator.
not rated yet Jul 31, 2013
"A good friend just told me yesterday that she was diagnosed with cancer. I know of many who have died of cancer. This kind of research will possibly yield huge benefits in our lives moving forward. Great work!"

Why don't you just pray harder? Why bother with all that pesky science when your god can just magic it away?
1 / 5 (1) Aug 14, 2013
[qWhy don't you just pray harder? Why bother with all that pesky science when your god can just magic it away?
I don't feel it's right to say that in this case. he actually did a good job of staying on topic and not attacking science with this post and was actually kind of positive and pro science.( if it was one of his anti science creationist worldview filled posts it would be justified, but not on this one about cancer and such)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.